期刊文献+

三苯基吡唑甲酮类化合物的合成及对6-OHDA 损伤的SH-SY5Y 细胞的保护作用

Synthesis of triphenylpyrazole ketone compounds and their protective action against 6-OHDA induced injury in SH-SY5Y cells
原文传递
导出
摘要 目的设计合成系列三苯基吡唑甲酮类化合物,测定其对6-羟基多巴胺(6-OHDA)损伤的SH-SY5Y细胞的保护作用,并初步探讨其构效关系。方法以2,5-二甲氧基苯乙酮为起始原料,经过Claisen-Schmidt反应和亲核加成合成目标化合物。采用CCK-8法考察了目标化合物对6-OHDA损伤的SH-SY5Y细胞的保护作用。结果与结论合成了8个未见文献报道的新化合物,其结构均经MS、1H-NMR、13C-NMR谱确证。体外活性筛选结果表明,化合物4c、4d、5c、5d具有较好的细胞保护作用,其EC50值为1.1~9.6μmol·L-1,与阳性对照雷沙吉兰相当(EC50=1.6μmol·L-1)。 A series of triphenylpyrazolone compounds were designed and synthesized,and their protective action against 6-OHDA induced SH-SY5 Y cell injury was evaluated.In this study,eight new target compounds were synthesized through Claisen-Schmidt reaction and nucleophilic addition with 2,5-dimethoxyacetophenone as the starting material,their structures were analyzed by MS,1H-NMR and 13C-NMR spectra.Preliminary results showed that the target compounds 4 c,4 d,5 c,and 5 d exhibited the excellent activity with the EC50values 1.1-9.6μmol·L-1,which were equivalent to the positive control rasagiline(EC50=1.6μmol·L-1).
作者 张乐华 冯秀娥 李青山 ZHANG Le-hua;FENG Xiu-e;LI Qing-shan(School of Pharmaceutical Science,Shanxi Medical University,Taiyuan 030001,China)
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2019年第4期268-272,共5页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(81473100) 国家科技重大专项(2018ZX09711001-001-017) 山西省重点研发计划(重点)项目(201703D111033)
关键词 三苯基吡唑甲酮 6-羟基多巴胺 SH-SY5Y细胞 保护作用 triphenylpyrazolone 6-hydroxydopamine SH-SY5Y cells protective action
  • 相关文献

参考文献2

二级参考文献22

  • 1ZHANG Feng-jiao1, YANG Jing-yu1, MOU Yan-hua1, SUN Bao-shan2, WANG Ji-ming3, WANG Fang1, WU Chun-fu1 1. Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China 2. Estaco Vitivinícola Nacional, Instituto National de Investigaco Agrária, Dois Portos 2565-191, Portugal 3. Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick Maryland 21702, USA.Oligomeric Procyanidins Induce Generation of Reactive Oxygen Species and Collapse of Mitochchondrial Membrane Potential in Glioblastoma Cell Lines[J].Chinese Herbal Medicines,2009,1(1):45-52. 被引量:3
  • 2冯波,王蓉,盛树力.神经退行性疾病研究中拟神经细胞模型:人神经母细胞瘤株SH-SY5Y的来源特性及应用[J].中国临床康复,2006,10(6):121-123. 被引量:62
  • 3Willis A W. Parkinson disease in the elderly adult[J]. Mo Med, 2013, 110(5):406-410.
  • 4Alonso A, Rodriguez L A, Logroscino G, et al. Gout and risk of Parkinson disease: a prospective study[J]. Neurology, 2007,69 (17):1696-1700.
  • 5Perier C, Bove J, Vila M. Mitochondria and programmed ceil death in Parkinson' s disease: apoptosis and beyond[J]. Antioxid Redox Signal, 2012,16(9):883-895.
  • 6Connolly B S, Lang A E. Pharmacological treatment of Parkinson disease: a review[J]. JAMA, 2014, 311(16):1670-1683.
  • 7Wu J B, Song N N, Wei X B, et al. Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose de- privation-induced injury[J]. J Neurol Sci, 2008, 264(1-2):50-55.
  • 8Su S Y, Cheng C Y, Tsai T H, et al. Paeonol protects memory after ischemic stroke via inhibiting ~ -secretase and apoptosis[J]. Evid Based Complement Alternat Med, 2012, 932823.
  • 9Zhou J, Zhou L, Hou D, et al. Paeonof increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer's disease[J]. Brain Res, 2011, 1388: 141-147.
  • 10Zhong S Z, Ge Q H, Qu R, et al. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice[J]. J Neurol Sci, 2009, 277(1-2):58-64.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部